| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/08/2006 | CA2253429C 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists |
| 08/08/2006 | CA2240571C The use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 08/08/2006 | CA2207258C Xanthine compounds having terminally aminated alkynol side chains |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/08/2006 | CA2193503C Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/08/2006 | CA2097063C Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 08/07/2006 | CA2496166A1 Health food product |
| 08/06/2006 | WO2006058869A2 Substituted pteridines for treating inflammatory diseases |
| 08/06/2006 | CA2587269A1 Substituted pteridines for treating inflammatory diseases |
| 08/03/2006 | WO2006081562A2 Synthesis of aryl pyrrolidones |
| 08/03/2006 | WO2006081554A2 Phenyl-substituted pyrrolidones |
| 08/03/2006 | WO2006081546A2 Inhibitor nucleic acids |
| 08/03/2006 | WO2006081522A2 Modulation of nmda receptor currents via orexin receptor and/or crf receptor |
| 08/03/2006 | WO2006081455A1 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 08/03/2006 | WO2006081452A2 Co-administration of perifosine with chemotherapeutics |
| 08/03/2006 | WO2006081445A2 Treatment of metastasized tumors |
| 08/03/2006 | WO2006081431A2 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | WO2006081392A1 N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids |
| 08/03/2006 | WO2006081391A2 Compounds for inflammation and immune-related uses |
| 08/03/2006 | WO2006081388A2 Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues |
| 08/03/2006 | WO2006081347A2 Controlled release compositions comprising an antipsychotic agent |
| 08/03/2006 | WO2006081343A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 08/03/2006 | WO2006081337A2 Erastin analogues and their uses for killing cancer cells |
| 08/03/2006 | WO2006081332A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 08/03/2006 | WO2006081327A2 Small molecules that reduce fungal growth |
| 08/03/2006 | WO2006081289A2 Antibacterial agents |
| 08/03/2006 | WO2006081280A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006081276A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 08/03/2006 | WO2006081273A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006081264A1 Antibacterial agents |
| 08/03/2006 | WO2006081252A2 Use of 1-benzyl-1-hydr0xy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds as analgesics |
| 08/03/2006 | WO2006081251A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/03/2006 | WO2006081182A2 Antibacterial agents |
| 08/03/2006 | WO2006081179A1 Antibacterial agents |
| 08/03/2006 | WO2006081178A2 Antibacterial agents |
| 08/03/2006 | WO2006081172A2 Compounds and compositions as protein kinase inhibitors |
| 08/03/2006 | WO2006081152A2 Estrogen receptor modulators |
| 08/03/2006 | WO2006081147A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 08/03/2006 | WO2006081127A2 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid |
| 08/03/2006 | WO2006081088A2 Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid |
| 08/03/2006 | WO2006081072A1 Antagonists of the mglu receptor and uses thereof |
| 08/03/2006 | WO2006080919A1 Method of producing a nicotine composition |
| 08/03/2006 | WO2006080884A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor |
| 08/03/2006 | WO2006080821A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 08/03/2006 | WO2006080780A1 Pharmaceutical compositions containing bisphosphonate for improving oral absorption |
| 08/03/2006 | WO2006080757A1 Novel use of ligands specific to fex-2 polypeptide |
| 08/03/2006 | WO2006080652A1 Process for preparing the intermediate compounds for pparalpha ligands |
| 08/03/2006 | WO2006080582A1 Agent for control of function of antigen-presenting cell |
| 08/03/2006 | WO2006080581A1 Agent for control of degranulation reaction and cytokine production |
| 08/03/2006 | WO2006080577A1 Indole derivatives |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080555A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 08/03/2006 | WO2006080533A1 3-amino-1,2,4-triazole derivative |
| 08/03/2006 | WO2006080524A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 08/03/2006 | WO2006080522A1 Food or drug comprising lactic acid bacterium containing mineral |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080509A1 Novel pyrimidine nucleoside compound or its salt |
| 08/03/2006 | WO2006080498A1 Tablets containing ornithine hydrochloride |
| 08/03/2006 | WO2006080484A1 Cefcapene pivoxil methanesulfonate |
| 08/03/2006 | WO2006080481A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | WO2006080477A1 Norvaline derivative and method for preparation thereof |
| 08/03/2006 | WO2006080463A1 Therapeutic agent for cancer and recurrence preventive each containing vitamin k hydroquinone derivative |
| 08/03/2006 | WO2006080451A1 Process for producing coated fine particle |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080449A1 Agent for drug clearance and accelerator for drug clearance |
| 08/03/2006 | WO2006080439A1 Tricyclic compound |
| 08/03/2006 | WO2006080430A1 Ophthalmic medicine composition |
| 08/03/2006 | WO2006080421A1 Spiroketal derivative and use thereof as diabetic medicine |
| 08/03/2006 | WO2006080415A1 Composition and method for treating or preventing bladder disorder |
| 08/03/2006 | WO2006080407A1 Ppar-activating compound |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006080328A1 Esterified catechin, process for producing the same, food and drink or cosmetic containing the same |
| 08/03/2006 | WO2006080327A1 ANTICANCER DRUG CONTAINING α,α,α-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR |
| 08/03/2006 | WO2006080323A1 Six-membered heterocyclic compound and the use thereof |
| 08/03/2006 | WO2006080312A1 Method for producing adsorptive porous body |
| 08/03/2006 | WO2006080311A1 Anthranilamide compound, method for producing same and pest control agent containing same |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006080262A1 Age-2 aptamer |
| 08/03/2006 | WO2006080199A1 Patch |
| 08/03/2006 | WO2006080118A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | WO2006080086A1 Composition for recovery from or prevention of central nervous system fatigue |
| 08/03/2006 | WO2006080043A2 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 08/03/2006 | WO2006080040A1 New potent and selective ligands of cannabinoid receptors |
| 08/03/2006 | WO2006080029A1 Extended release formulation of levetiracetam |
| 08/03/2006 | WO2006080017A2 Biologically active silver-coated proteins |
| 08/03/2006 | WO2006079988A1 7- {4- [2- (2 , 6-dichl0r0-4-methylphen0xy) ethoxy] phenyl}-3 , 9-diazabicyclo [3 .3 . 31] non - 6-ene- s- carboxylic acid cyclopropyl- (2 , 3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension |
| 08/03/2006 | WO2006079923A2 Form iv crystalline celecoxib |
| 08/03/2006 | WO2006079916A1 Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
| 08/03/2006 | WO2006079910A2 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity |
| 08/03/2006 | WO2006079853A1 Analgesic compositions |
| 08/03/2006 | WO2006079841A1 Nebulizer formulation |
| 08/03/2006 | WO2006079833A1 Quinazoline derivatives as antiviral agents |
| 08/03/2006 | WO2006079829A1 Phosphoglycerides for use in improving heart rate recovery and increasing exercise capacity |
| 08/03/2006 | WO2006079815A1 Stabilised plant extract and its therapeutic use |
| 08/03/2006 | WO2006079811A1 Reducing drug dependence or addiction |
| 08/03/2006 | WO2006079809A1 Compounds for treating urinary incontinence |
| 08/03/2006 | WO2006079796A1 Treatment for mucositis |
| 08/03/2006 | WO2006079792A1 Methods of autophagy induction in mammalian cells |